Publications: details revised at 2 of 11 entries
Study Status, Oversight, Referencesv12
Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00005485 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
Track this trialPublications: details revised at 2 of 11 entries
Study Status, Oversight, Referencesv12
Trial status: Enrolling by Invitation to Active, Not Recruiting
Enrollment target: estimated 3000 to confirmed 5306; Study description shortened, about 61 words
Study Status, Oversight, Study Description, Study Design, Eligibility, IPDSharingv11
Primary and study completion dates: Apr 12, 2025 to Aug 12, 2025
Study Statusv10
Primary and study completion dates: Apr 12, 2023 to Apr 12, 2025
Study description shortened, about 12 words
Study Status, Study Descriptionv9
Trial status: Suspended to Enrolling by Invitation
Enrollment target: 5306 to 3000; Primary and study completion dates: Aug 2024 to Apr 12, 2023; Start date: Sep 2000 to Sep 19, 2000; and 1 more
Study Status, Conditions, Study Design, Contacts/Locationsv8
Trial status: Active, Not Recruiting to Suspended
Sponsor's reason: COVID-19 outbreak
Study sites: 3 to 1; Study description shortened, about 4 words
Study Identification, Study Status, Oversight, Study Description, Outcome Measures, Contacts/Locations, IPDSharingv7
Primary and study completion dates: Aug 2024
Study description shortened, about 37 words; Study title revised
Study Identification, Study Status, Study Description, Contacts/Locations, IPDSharingv6
Start date: Oct 1996 to Sep 2000
Trial status: Recruiting to Active, Not Recruiting; Enrollment target: estimated 5307 to confirmed 5306; Study sites: 1 to 3; and 2 more
Study Identification, Study Status, Sponsor/Collaborators, Oversight, Study Design, Eligibility, Contacts/Locations, IPDSharing, Referencesv5
Study description expanded, about 2 words
Site contact updated; Publications: 10 to 11
Study Status, Study Description, Study Design, Contacts/Locations, Referencesv4
Enrollment target: 5307
Completion date: May 2013 to not stated; Eligibility criteria expanded, about 1 word; Study description shortened, about 69 words; and 1 more
Study Identification, Study Status, Study Description, Study Design, Eligibilityv3
Study Status
Re-verified, no change to tracked fields
v2
Study First Submitted
| NCT Number | NCT00005485 |
| Lead Sponsor | National Heart, Lung, and Blood Institute (NHLBI)
Collaborators: National Institute on Minority Health and Health Disparities (NIMHD) |
| Conditions | Cardiovascular Diseases, Heart Diseases, Atherosclerosis, Coronary Disease, Hypertension, Cerebrovascular Disorders |
| Enrollment | 5,306 participants |
| Start Date | |
| Primary Completion | (estimated) |
| Study Completion | (estimated) |
| Updated on ClinicalTrials.gov |